Article | Published:

Genetically encoded reporters for hyperpolarized xenon magnetic resonance imaging

Nature Chemistry volume 6, pages 629634 (2014) | Download Citation

Abstract

Magnetic resonance imaging (MRI) enables high-resolution non-invasive observation of the anatomy and function of intact organisms. However, previous MRI reporters of key biological processes tied to gene expression have been limited by the inherently low molecular sensitivity of conventional 1H MRI. This limitation could be overcome through the use of hyperpolarized nuclei, such as in the noble gas xenon, but previous reporters acting on such nuclei have been synthetic. Here, we introduce the first genetically encoded reporters for hyperpolarized 129Xe MRI. These expressible reporters are based on gas vesicles (GVs), gas-binding protein nanostructures expressed by certain buoyant microorganisms. We show that GVs are capable of chemical exchange saturation transfer interactions with xenon, which enables chemically amplified GV detection at picomolar concentrations (a 100- to 10,000-fold improvement over comparable constructs for 1H MRI). We demonstrate the use of GVs as heterologously expressed indicators of gene expression and chemically targeted exogenous labels in MRI experiments performed on living cells.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    & Development and use of fluorescent protein markers in living cells. Science 300, 87–91 (2003).

  2. 2.

    Image formation by induced local interactions: examples employing nuclear magnetic resonance. Nature 242, 190–191 (1973).

  3. 3.

    , , & Developing MR reporter genes: promises and pitfalls. NMR Biomed. 20, 275–290 (2007).

  4. 4.

    , , , & Dynamic imaging with MRI contrast agents: quantitative considerations. Magn. Reson. Imaging 24, 449–462 (2006).

  5. 5.

    , , , & Use of the green fluorescent protein and its mutants in quantitative fluorescence microscopy. Biophys. J. 73, 2782–2790 (1997).

  6. 6.

    et al. Biological magnetic resonance imaging using laser-polarized 129Xe. Nature 370, 199–201 (1994).

  7. 7.

    Increase in signal-to-noise ratio of >10,000 times in liquid-state NMR. Proc. Natl Acad. Sci. USA 100, 10158–10163 (2003).

  8. 8.

    & Spin-exchange optical pumping of noble-gas nuclei. Rev. Mod. Phys. 69, 629–642 (1997).

  9. 9.

    et al. Imaging alveolar–capillary gas transfer using hyperpolarized 129Xe MRI. Proc. Natl Acad. Sci. USA 103, 18278–18283 (2006).

  10. 10.

    et al. Brain MRI with laser-polarized 129Xe. Magn Reson Med 38, 695–698 (1997).

  11. 11.

    , , , & Distribution and dynamics of laser-polarized 129Xe magnetization in vivo. Magn. Reson. Med. 42, 1137–1145 (1999).

  12. 12.

    , , , & Spin-lattice relaxation of laser-polarized xenon in human blood. Proc. Natl Acad. Sci. USA 96, 3664–3669 (1999).

  13. 13.

    et al. Reinvestigating hyperpolarized 129Xe longitudinal relaxation time in the rat brain with noise considerations. NMR Biomed. 21, 217–225 (2008).

  14. 14.

    et al. Functionalized xenon as a biosensor. Proc. Natl Acad. Sci. USA 98, 10654–10657 (2001).

  15. 15.

    , , , & 129Xe and 1H NMR study of the reversible trapping of xenon by cryptophane-A in organic solution. J. Am. Chem. Soc. 120, 784–791 (1998).

  16. 16.

    et al. Water soluble cryptophanes showing unprecedented affinity for xenon: candidates as NMR-based biosensors. J. Am. Chem. Soc. 128, 6239–6246 (2006).

  17. 17.

    , & Nanoemulsion contrast agents with sub-picomolar sensitivity for xenon NMR. J. Am. Chem. Soc. 135, 9576–9579 (2013).

  18. 18.

    et al. Development of a functionalized xenon biosensor. J. Am. Chem. Soc. 126, 15287–15294 (2004).

  19. 19.

    , , , & Molecular imaging using a targeted magnetic resonance hyperpolarized biosensor. Science 314, 446–449 (2006).

  20. 20.

    et al. Temperature response of 129Xe depolarization transfer and its application for ultrasensitive NMR detection. Phys. Rev. Lett. 100, 257603 (2008).

  21. 21.

    et al. A xenon-based molecular sensor assembled on an MS2 viral capsid scaffold. J. Am. Chem. Soc. 132, 5936–5937 (2010).

  22. 22.

    , & Utilizing a water-soluble cryptophane with fast xenon exchange rates for picomolar sensitivity NMR measurements. Anal. Chem. 84, 9935–9941 (2012).

  23. 23.

    & Functionalized 129Xe contrast agents for magnetic resonance imaging. Curr. Opin. Chem. Biol. 14, 97–104 (2010).

  24. 24.

    , , , & Shorter synthesis of trifunctionalized cryptophane-A derivatives. Org. Lett. 13, 1414–1417 (2011).

  25. 25.

    et al. Molecular imaging of cancer cells using a bacteriophage-based 129Xe NMR biosensor. Angew. Chem. Int. Ed. 52, 4849–4853 (2013).

  26. 26.

    et al. Designing 129Xe NMR biosensors for matrix metalloproteinase detection. J. Am. Chem. Soc. 128, 13274–13283 (2006).

  27. 27.

    et al. Design and synthesis of new cryptophanes with intermediate cavity sizes. Org. Lett. 13, 2153–2155 (2011).

  28. 28.

    Distribution, formation and regulation of gas vesicles. Nature Rev. Microbiol. 10, 705–715 (2012).

  29. 29.

    Gas vesicles. Microbiol. Rev. 58, 94–144 (1994).

  30. 30.

    Permeability of gas vesicles to perfluorocyclobutane. J. Gen. Microbiol. 128, 1679–1684 (1982).

  31. 31.

    & Gas vesicle genes identified in Bacillus megaterium and functional expression in Escherichia coli. J. Bacteriol. 180, 2450–2458 (1998).

  32. 32.

    Principles of Nuclear Magnetism (Oxford Univ. Press, 1983).

  33. 33.

    & Limiting equations for exchange broadening in two-site NMR systems with very unequal populations. J. Magn. Reson. (1969) 32, 339–343 (1978).

  34. 34.

    , , , & T2 exchange agents: a new class of paramagnetic MRI contrast agent that shortens water T2 by chemical exchange rather than relaxation. Magn. Reson. Med. 66, 1697–1703 (2011).

  35. 35.

    et al. Distribution of hyperpolarized xenon in the brain following sensory stimulation: preliminary MRI findings. PLoS One 6, e21607 (2011).

  36. 36.

    et al. MRI of stroke using hyperpolarized 129Xe. NMR Biomed. 24, 170–175 (2011).

  37. 37.

    et al. Determinants of tissue delivery for 129Xe magnetic resonance in humans. Magn. Reson. Med. 36, 340–344 (1996).

  38. 38.

    et al. The pharmacokinetics of hyperpolarized xenon: implications for cerebral MRI. J. Magn. Reson. Imag. 7, 848–854 (1997).

  39. 39.

    , , & Fluorine (19F) MRS and MRI in biomedicine. NMR Biomed. 24, 114–129 (2011).

  40. 40.

    et al. Artificial reporter gene providing MRI contrast based on proton exchange. Nature Biotechnol. 25, 217–219 (2007).

  41. 41.

    et al. New ‘multicolor’ polypeptide diamagnetic chemical exchange saturation transfer (DIACEST) contrast agents for MRI. Magn. Reson. Med. 60, 803–812 (2008).

  42. 42.

    , , & Micro-engineered local field control for high-sensitivity multispectral MRI. Nature 453, 1058–1063 (2008).

  43. 43.

    & Synthetic biology: applications come of age. Nature Rev. Genet. 11, 367–379 (2010).

  44. 44.

    Models and approaches to dissect host–symbiont specificity. Trends Microbiol. 18, 504–511 (2010).

  45. 45.

    , & Molecular imaging of host–pathogen interactions in intact small animals. Cell Microbiol. 6, 319–331 (2004).

  46. 46.

    Engineering the perfect (bacterial) cancer therapy. Nature Rev. Cancer 10, 785–794 (2010).

  47. 47.

    , & Molecular engineering of viral gene delivery vehicles. Annu. Rev. Biomed. Eng. 10, 169–194 (2008).

  48. 48.

    , , & Cassette-based presentation of SIV epitopes with recombinant gas vesicles from halophilic archaea. J. Biotechnol. 114, 225–237 (2004).

  49. 49.

    et al. Xenon-129 MR imaging and spectroscopy of rat brain using arterial delivery of hyperpolarized xenon in a lipid emulsion. Magn. Reson. Med. 46, 208–212 (2001).

  50. 50.

    et al. In vivo MR imaging of pulmonary perfusion and gas exchange in rats via continuous extracorporeal infusion of hyperpolarized 129Xe. PLoS one 7, e31306 (2012).

Download references

Acknowledgements

We thank P. Dao for assistance with NMR measurements, M. Cannon for providing the pNL29 plasmid and R. Zalpuri and K. McDonald for assistance with electron microscopy. This work was supported by the Miller Research Fellowship and Burroughs Wellcome Career Award at the Scientific Interface (M.G.S.), California Institute For Regenerative Medicine grant RT2-02022 (D.V.S.) and Department of Energy contract DE-AC02-05CH11231 (A.P., V.S.B).

Author information

Affiliations

  1. Miller Research Institute, University of California, Berkeley, Berkeley, California 94720, USA

    • Mikhail G. Shapiro
  2. Department of Bioengineering, University of California, Berkeley, Berkeley, California 94720, USA

    • Mikhail G. Shapiro
    • , George Sun
    •  & David V. Schaffer
  3. Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, California 94720, USA

    • Mikhail G. Shapiro
  4. Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, California 91125, USA

    • Mikhail G. Shapiro
  5. Department of Chemical and Biomolecular Engineering, University of California, Berkeley, Berkeley, California 94720, USA

    • R. Matthew Ramirez
    • , Jinny Sun
    • , Alexander Pines
    •  & Vikram S. Bajaj
  6. Materials Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA

    • R. Matthew Ramirez
    • , Lindsay J. Sperling
    • , Alexander Pines
    •  & Vikram S. Bajaj
  7. Department of Chemistry, University of California, Berkeley, Berkeley, California 94720, USA

    • David V. Schaffer

Authors

  1. Search for Mikhail G. Shapiro in:

  2. Search for R. Matthew Ramirez in:

  3. Search for Lindsay J. Sperling in:

  4. Search for George Sun in:

  5. Search for Jinny Sun in:

  6. Search for Alexander Pines in:

  7. Search for David V. Schaffer in:

  8. Search for Vikram S. Bajaj in:

Contributions

M.G.S. conceived and directed the study. M.G.S., R.M.R., V.S.B. and L.J.S. designed the experiments. M.G.S., R.M.R., J.S. and L.J.S. performed NMR measurements. M.G.S. prepared the GVs, bacteria and mammalian cells. M.G.S. and G.S. generated E. coli genetic constructs. M.G.S., R.M.R. and J.S. analysed the data. M.G.S. wrote the manuscript with interpretation and input from all authors. M.G.S. and V.S.B. provided supervision with input from A.P. and D.V.S.

Competing interests

The authors declare no competing financial interests.

Corresponding authors

Correspondence to Mikhail G. Shapiro or Vikram S. Bajaj.

Supplementary information

PDF files

  1. 1.

    Supplementary information

    Supplementary information

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/nchem.1934

Further reading